Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder
NCT ID: NCT06874868
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2024-09-15
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the aim of this study is to evaluate whether patients with TMD have higher levels of salivary cortisol compared to the general population.
Initially, an assessment will be conducted using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol to determine whether the patient suffer of any kind of Temporomandibular Disorder. Based on the results, individuals will be classified into two groups: the study group, consisting of patients with TMD, and the control group, composed of individuals without the disorder.
Those who agree to participate will be required to sign an informed consent form. Subsequently, a saliva sample will be collected for analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Diurnal Salivary Cortisol Production in COVID-19
NCT04988269
Evaluation of Emotion-related Salivary Molecular Biomarkers
NCT07320040
Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
NCT06008184
Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures
NCT01673087
Salivary Biomarkers for Concussion
NCT06149351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group
Control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Coimbra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Macedo de Sousa
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine of University of Coimbra
Coimbra, Coimbra District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMUCMD2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.